Page 207 - Read Online

46. Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, of apoptosis in brain cancer cells by targeted codelivery of
Tao N, Rosenfeld-Franklin M, Lerner L, Chiu MI, Wild R, siRNA and anticancer drugs. Mol Pharm 2011;8:1955-61.
Epstein D, Pachter JA, Miglarese MR. Compensatory insulin 56. Kunnath AP, Tiash S, Fatemian T, Morshed M, Mohamed SM,
receptor (IR) activation on inhibition of insulin-like growth Chowdhury EH. Intracellular delivery of ERBB2 siRNA and
factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R p53 gene synergistically inhibits the growth of established
and IR in cancer. Mol Cancer Ther 2010;9:2652-64. tumour in an immunocompetent mouse. J Cancer Sci Ther
47. Flanigan SA, Pitts TM, Eckhardt SG, Tentler JJ, Tan AC, 2014;6:99-104.
Thorburn A, Leong S. The insulin-like growth factor I 57. Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
receptor/insulin receptor tyrosine kinase inhibitor PQIP Folate-linked lipid-based nanoparticles for synthetic siRNA
exhibits enhanced antitumor effects in combination with delivery in KB tumor xenografts. Eur J Pharm Biopharm
chemotherapy against colorectal cancer models. Clin Cancer 2008;70:718-25.
Res 2010;16:5436-46. 58. Kunnath AP, Kamaruzman NI, Chowdhury EH.
48. Chen YF, Fu LW. Mechanisms of acquired resistance to Nanoparticle-facilitated intratumoral delivery of Bcl-2/IGF-1R
tyrosine kinase inhibitors. Acta Pharm Sin B 2011;1:197-207. siRNAs and p53 Gene synergistically inhibits tumor growth
49. Taeger J, Moser C, Hellerbrand C, Mycielska ME, Glockzin G, in immunocompetent mice. J Nanomedicine Nanotechnol
Schlitt HJ, Geissler EK, Stoeltzing O, Lang SA. Targeting 2014;S9:001.
FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, 59. Niu J, Xu Z, Li XN, Han Z. siRNA-mediated type 1
and metastasis by effects on tumor cells, endothelial cells, insulin-like growth factor receptor silencing induces
and pericytes in pancreatic cancer. Mol Cancer Ther chemosensitization of a human liver cancer cell line with
2011;10:2157-67. mutant P53. Cell Biol Int 2007;31:156-64.
50. Escudier B, Grünwald V, Ravaud A, Ou YC, Castellano D, 60. Xie L, Kassner M, Munoz RM, Que QQ, Kiefer J, Zhao Y,
Lin CC, Gschwend JE, Harzstark A, Beall S, Pirotta N, Mousses S, Yin HH, Von Hoff DD, Han H. Kinome-wide
Squires M, Shi M, Angevin E. Phase II results of siRNA screening identifi es molecular targets mediating
Dovitinib (TKI258) in patients with metastatic renal cell the sensitivity of pancreatic cancer cells to Aurora kinase
cancer. Clin Cancer Res 2014;20:3012-22. inhibitors. Biochem Pharmacol 2012;83:452-61.
51. André F, Bachelot T, Campone M, Dalenc F, 61. Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C,
Perez-Garcia JM, Hurvitz SA, Turner N, Rugo H, Smith JW, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T,
Deudon S, Shi M, Zhang Y, Kay A, Porta DG, Yovine A, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC,
Baselga J. Targeting FGFR with dovitinib (TKI258): Palacios J, Lakhani SR, Ashworth A. FGFR1 emerges as a
potential therapeutic target for lobular breast carcinomas. Clin
preclinical and clinical data in breast cancer. Clin Cancer Cancer Res 2006;12:6652-62.
Res 2013;19:3693-702.
52. Kalota A, Shetzline SE, Gewirtz AM. Progress in the 62. Turner N, Pearson A, Sharpe R, Lambros M, Geyer F,
Lopez-Garcia MA, Natrajan R, Marchio C, Iorns E,
development of nucleic acid therapeutics for cancer. Cancer Mackay A, Gillett C, Grigoriadis A, Tutt A, Reis-Filho JS,
Biol Ther 2004;3:4-12. Ashworth A. FGFR1 amplifi cation drives endocrine therapy
53. Lu PY, Xie F, Woodle MC. In vivo application of RNA resistance and is a therapeutic target in breast cancer. Cancer
interference: from functional genomics to therapeutics. Adv Res 2010;70:2085-94.
Genet 2005;54:117-42. 63. Niu J, Li XN, Qian H, Han Z. siRNA mediated the type 1
54. Chowdhury EH. Nuclear targeting of viral and non-viral DNA. insulin-like growth factor receptor and epidermal growth
Expert Opin Drug Deliv 2009;6:697-703. factor receptor silencing induces chemosensitization of liver
55. Kim C, Shah BP, Subramaniam P, Lee KB. Synergistic induction cancer cells. J Cancer Res Clin Oncol 2008;134:503-13.

200 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦